These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 25394896)

  • 21. Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy.
    Patterson K; Arya L; Bottomley S; Morgan S; Cox A; Catto J; Bryant HE
    Oncotarget; 2016 Nov; 7(46):76140-76150. PubMed ID: 27764811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exome Sequencing in a Family Identifies RECQL5 Mutation Resulting in Early Myocardial Infarction.
    Xie X; Zheng YY; Adi D; Yang YN; Ma YT; Li XM; Fu ZY; Ma X; Liu F; Yu ZX; Chen Y; Huang Y
    Medicine (Baltimore); 2016 Feb; 95(5):e2737. PubMed ID: 26844521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.
    Arora A; Abdel-Fatah TM; Agarwal D; Doherty R; Croteau DL; Moseley PM; Hameed K; Green A; Aleskandarany MA; Rakha EA; Patterson K; Ball G; Chan SY; Ellis IO; Bohr VA; Bryant HE; Madhusudan S
    Carcinogenesis; 2016 Jan; 37(1):63-71. PubMed ID: 26586793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RECQL: a new breast cancer susceptibility gene.
    Banerjee T; Brosh RM
    Cell Cycle; 2015; 14(22):3540-3. PubMed ID: 26125302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer.
    Sun J; Wang Y; Xia Y; Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Lou H; Xie Y
    PLoS Genet; 2015 May; 11(5):e1005228. PubMed ID: 25945795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between RECQL5 genetic polymorphisms and susceptibility to breast cancer.
    He YJ; Qiao ZY; Gao B; Zhang XH; Wen YY
    Tumour Biol; 2014 Dec; 35(12):12201-4. PubMed ID: 25394896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haplotype analysis of RECQL5 gene and laryngeal cancer.
    Qi Y; Zhou X
    Tumour Biol; 2014 Mar; 35(3):2669-73. PubMed ID: 24213927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of RECQL5 gene polymorphisms and osteosarcoma in a Chinese Han population.
    Zhi LQ; Ma W; Zhang H; Zeng SX; Chen B
    Tumour Biol; 2014 Apr; 35(4):3255-9. PubMed ID: 24287950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single nucleotide polymorphism in the RECQL5 gene increased osteosarcoma susceptibility in a Chinese Han population.
    Dong YZ; Huang YX; Lu T
    Genet Mol Res; 2015 Mar; 14(1):1899-902. PubMed ID: 25867335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between DNA methyltransferases 3B gene polymorphisms and the susceptibility to acute myeloid leukemia in Chinese Han population.
    Zheng Q; Zeng TT; Chen J; Liu H; Zhang H; Su J
    PLoS One; 2013; 8(9):e74626. PubMed ID: 24069326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A genetic variant in the promoter of APE1 gene (-656 T>G) is associated with breast cancer risk and progression in a Chinese population.
    Kang H; Dai Z; Ma X; Ma L; Jin Y; Liu X; Wang X
    Gene; 2013 Nov; 531(1):97-100. PubMed ID: 23994194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of 677 C>T (rs1801133) and 1298 A>C (rs1801131) polymorphisms in the MTHFR gene and breast cancer susceptibility: a meta-analysis based on 57 individual studies.
    Li K; Li W; Dong X
    PLoS One; 2014; 9(6):e71290. PubMed ID: 24945727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.
    Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T
    Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphism of miR-196a as a prognostic biomarker for early breast cancer.
    Lee SJ; Seo JW; Chae YS; Kim JG; Kang BW; Kim WW; Jung JH; Park HY; Jeong JY; Park JY
    Anticancer Res; 2014 Jun; 34(6):2943-9. PubMed ID: 24922658
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.